A phase II trial of docetaxel in the treatment of elderly patients (aged 70 or over) with non-small cell lung cancer

Trial Profile

A phase II trial of docetaxel in the treatment of elderly patients (aged 70 or over) with non-small cell lung cancer

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2012

At a glance

  • Drugs Docetaxel (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms ELTAX
  • Most Recent Events

    • 01 Aug 2012 Actual end date (Jan 2009) added as reported by ISRCTN: Current Controlled Trials record.
    • 01 Aug 2012 Status changed from completed to discontinued as reported by ISRCTN: Current Controlled Trials record.
    • 01 Jan 2009 Status changed from unconfirmed to completed as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top